
Illustration: Reuters
').insertAfter(".article-content__img");$(".article-content__img div").find('div').remove();
Topics
AstraZeneca | Pharma sector | Companies

Illustration: Reuters
').insertAfter(".article-content__img");$(".article-content__img div").find('div').remove();
AstraZeneca Pharma India on Wednesday said Gagandeep Singh Bedi has resigned from the post of managing director.
The drug firm said it has approved the appointment of Sanjeev Panchal as its managing director for a period of three years with effect from January 1, 2023.
Panchal had joined AstraZeneca Pharma in February 2003 as Brand Associate and progressed through several positions in India, Indonesia, Asia Pacific and the international region, based in Singapore and the United Kingdom (UK), it said.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!
First Published: Wed, December 14 2022. 21:58 IST
Monzo is preparing a renewed push to secure a US banking licence, four years after abandoning its first attempt when tal... Read more
America’s cryptocurrency companies are scrambling to secure a foothold in the country’s traditional banking system, ... Read more
Parallel Banking: How Stablecoins Are Building a New Global Payments SystemStablecoins—digital currencies pegged to tr... Read more
JPMorgan has deployed an AI-based research analyst chatbot to enhance productivity among its workforce, with approximate... Read more
Private equity has emerged as a significant force in the global financial landscape, driving substantial growth and inve... Read more
The world’s leading financial stability watchdog has issued a warning about the unresolved vulnerabilities within the ... Read more